KQED Nightly Business Report May 19, 2015
Street today. Two major retail names are getting together. It was endo that ended up being the biggest acquirer. With an agreement to buy par pharmaceuticals. The deal will make Endo International an even bigger player in the fast changing and fast consolidating generic drug sector. Shares of endofell more than 5 . Bertha coombs has more on the deal. Repor drug makers that produce generic drugs are attracting big bucks. Endopaying 8 billion for par pharmaceutical 13e6kly in generics this will position us as a top generics player in the u. S. Endos shares fell some analysts citing costs, par ph...